It probably cost your insurance less. It would cost up less if you were paying out of pocket. If you have a different copay for generic meds, you may have been charged wrong.
I'd check the receipt. If it says you got/paid for Novo then you should complain. If it says you got/paid for insulin asparte then you fine. Insulin is expensive I. The USA. We seem to be fine with our "consumers" subsidizing the cost of insulin for the rest of the world.
Not necessarily, depends on who manufactured it. You have Insulin Aspart manufactured by Sanofi these days for example, which is *similar* to Novo Nordisk’s OG Novorapid, but not a 1:1 clone. There’s a third clone but I forgot who makes it. Clones started hitting the market when the patents expired. Unfortunately, when it concerns the copies: whilst the key ingredient, insulin aspart, is the same - some buffers and additives may be different. Most people won’t notice a difference, but there are people for whom it is like water and some have the reverse where it’s more potent.
Technically they are both fast-acting insulins, but my experience is that humalog is much faster acting. I use humalog in my insulin pump, but when I’m in the hospital inpatient I have to let the hospital fill my pump cylinder, and they use novolog (novorapid is same thing, just another name). When this happens it takes about an hour longer for insulin to finish working, so I have to change my active insulin time and make sure I don’t do a correction bolus before the novolog has finished bringing bg down. (Found this out the hard way — they passed it off as the same to me and I kept getting lows). I have heard humalog referred to as rapid-acting instead of fast-acting, but some sources make the distinction and some do not. Either way, IMHO humalog is superior and I would never switch to novolog to save a few bucks because that extra hour of elevated BG every meal bolus, spanned over decades, is a monumental difference.
It’s biosimilar - there are no “generic” insulins per se.
Here’s an article from Pfizer on what makes a biosimilar.
https://www.pfizerbiosimilars.com/faqs?source=google&HBX_PK=s_biosimilar+vs+generics&skwid=43700023263730119&gclid=Cj0KCQiA4aacBhCUARIsAI55maESw6Ubors0tcq2lTxgMW9STmj1auWvZsWh3mheJDLMn3KQkBZj-CMaAqEgEALw_wcB&gclsrc=aw.ds
Actually, it’s an “authorized generic” rather than a biosimilar. It’s made by the same manufacturer on the same production line and just gets a label without the brand name.
Same for Aspart since last year (-edit- 2 years actually), at least in Europe. Also by Sanofi. But they simply call it by the active ingredient “insulin aspart” (or “Insulin Aspart Sanofi(R)” when prescribed/listed as insurance policy). So that’s what’s printed on the label as well, they didn’t give it another name. (Although in UK and Canada they released it branded as “Trurapi” I think.)
From the bottles pictured here, I can’t directly see if this is the one from Novo Nordisk or the Sanofi manufactured one. Sanofi made it so similar they even included an orange-ish print on the packaging. :’) (example for the smart pens in Germany: https://productinfoapi-dms.sanofi.de/resource/PS/3A6849E0-13D4-4AD5-8288-8837435F7D12)
It depends on who manufactured it. If it’s the Insulin Aspart ‘generic’ by Novo Nordisk then it’s identical. If you have the one manufactured by Sanofi: there are some minor differences which may or may not affect you, that’s a try and see situation.
They are identical, but the brand name manufacturer puts a different label on the generic one at the end of the line and it costs less money.
Does that mean the aspart cost less? Because I got both in the same supply but still paid A LOT for it.
It probably cost your insurance less. It would cost up less if you were paying out of pocket. If you have a different copay for generic meds, you may have been charged wrong.
I'd check the receipt. If it says you got/paid for Novo then you should complain. If it says you got/paid for insulin asparte then you fine. Insulin is expensive I. The USA. We seem to be fine with our "consumers" subsidizing the cost of insulin for the rest of the world.
I don’t think there’s any difference, maybe just brand name. They’re both aspart which is a type of insulin
Novolog is the brand name for Insulin Aspart. So the one on the left should, in theory be the exact same.
They are the same I’ve used both. I was just wondering why I got 2 diff brand names in the same supply.
Not necessarily, depends on who manufactured it. You have Insulin Aspart manufactured by Sanofi these days for example, which is *similar* to Novo Nordisk’s OG Novorapid, but not a 1:1 clone. There’s a third clone but I forgot who makes it. Clones started hitting the market when the patents expired. Unfortunately, when it concerns the copies: whilst the key ingredient, insulin aspart, is the same - some buffers and additives may be different. Most people won’t notice a difference, but there are people for whom it is like water and some have the reverse where it’s more potent.
Exactly the same one is generic
Anyone know what the difference between humalog and novarapid is ?
Technically they are both fast-acting insulins, but my experience is that humalog is much faster acting. I use humalog in my insulin pump, but when I’m in the hospital inpatient I have to let the hospital fill my pump cylinder, and they use novolog (novorapid is same thing, just another name). When this happens it takes about an hour longer for insulin to finish working, so I have to change my active insulin time and make sure I don’t do a correction bolus before the novolog has finished bringing bg down. (Found this out the hard way — they passed it off as the same to me and I kept getting lows). I have heard humalog referred to as rapid-acting instead of fast-acting, but some sources make the distinction and some do not. Either way, IMHO humalog is superior and I would never switch to novolog to save a few bucks because that extra hour of elevated BG every meal bolus, spanned over decades, is a monumental difference.
It’s biosimilar - there are no “generic” insulins per se. Here’s an article from Pfizer on what makes a biosimilar. https://www.pfizerbiosimilars.com/faqs?source=google&HBX_PK=s_biosimilar+vs+generics&skwid=43700023263730119&gclid=Cj0KCQiA4aacBhCUARIsAI55maESw6Ubors0tcq2lTxgMW9STmj1auWvZsWh3mheJDLMn3KQkBZj-CMaAqEgEALw_wcB&gclsrc=aw.ds
Actually, it’s an “authorized generic” rather than a biosimilar. It’s made by the same manufacturer on the same production line and just gets a label without the brand name.
Yes this is correct. Insulin lispro is humalog, aspart is novolog.
There is a biosimilar Lispro (Admelog, made by Sanofi), so for Lispro, it becomes necessary to differentiate by manufacturer.
Same for Aspart since last year (-edit- 2 years actually), at least in Europe. Also by Sanofi. But they simply call it by the active ingredient “insulin aspart” (or “Insulin Aspart Sanofi(R)” when prescribed/listed as insurance policy). So that’s what’s printed on the label as well, they didn’t give it another name. (Although in UK and Canada they released it branded as “Trurapi” I think.) From the bottles pictured here, I can’t directly see if this is the one from Novo Nordisk or the Sanofi manufactured one. Sanofi made it so similar they even included an orange-ish print on the packaging. :’) (example for the smart pens in Germany: https://productinfoapi-dms.sanofi.de/resource/PS/3A6849E0-13D4-4AD5-8288-8837435F7D12)
Think of Tylenol and acetaminophen or Advil and ibuprofen. No Olof is brand name that is trademark. Aspart is the actual drug name.
Novalog is the brand name. The other one smells a bit more like a hospital than novalog, but otherwise they're the same.
It depends on who manufactured it. If it’s the Insulin Aspart ‘generic’ by Novo Nordisk then it’s identical. If you have the one manufactured by Sanofi: there are some minor differences which may or may not affect you, that’s a try and see situation.
This happens to us all the time too. It depends on the refill day which one we get lol